Table 1 The intraperitoneal administration of 10, 20 and 50 nm GNPs in rats for periods of 3 or 7 days

Control

received no gold nanoparticles (GNPs; n = 10)

G1A

received infusion of 50 μl GNPs of size 10 nm for 3 days (n = 5)

G1B

received infusion of 50 μl GNPs of size 10 nm for 7 days (n = 5)

G2A

received infusion of 50 μl GNPs of size 20 nm for 3 days (n = 5)

G2B

received infusion of 50 μl GNPs of size 20 nm for 7 days (n = 5)

G3A

received infusion of 50 μl GNPs of size 50 nm for 3 days (n = 5)

G3B

received infusion of 50 μl GNPs of size 50 nm for 7 days (n = 5)

G4A

received infusion of 100 μl GNPs of size 10 nm for 3 days (n = 5)

G4B

received infusion of 100 μl GNPs of size 10 nm for 7 days (n = 5)

G5A

received infusion of 100 μl GNPs of size 20 nm for 3 days (n = 5)

G5B

received infusion of 100 μl GNPs of size 20 nm for 7 days (n = 5)

G6A

received infusion of 100 μl GNPs of size 50 nm for 3 days (n = 5)

G6B

received infusion of 100 μl GNPs of size 50 nm for 7 days (n = 5)